Preclinical Investigation of Tian-Zhi-Kang as A Candidate Therapeutic Agent Against Multiple Human Cancer Types

Grants and Contracts Details

StatusActive
Effective start/end date6/1/24 → 6/30/26

Funding

  • Changzhou Yujing BioTech Company LTD: $110,000.00